Flora Peyvandi/X
Aug 29, 2025, 19:05
Flora Peyvandi: Global Estimates Highlight Treatment of Bleeding Episodes in VWD and Hemophilia A with Desmopressin
Flora Peyvandi, Professor of Internal Medicine-Hemostasis and Thrombosis Unit, University of Milan, former President of ISTH, shared on X:
”Global estimation of the bleeding episodes treatable with desmopressin in von Willebrand disease and hemophilia A.”
Read the full article here.
Title: Global estimation of the bleeding episodes treatable with desmopressin in von Willebrand disease and hemophilia A
Authors: Alessandro Gringeri, Pier Mannuccio Mannucci, Michele Gringeri, Giancarlo Castaman, Flora Peyvandi
Stay updated on the latest scientific advancements with Hemostasis Today.
-
Mar 6, 2026, 16:51Priya Reehal: Highlighting The Central Role of Nurses in Cardio-Oncology
-
Mar 6, 2026, 16:50Rainer Kaiser: Blinatumomab Shows Remarkable Response in Multi-Refractory ITP and APS
-
Mar 6, 2026, 16:18Laila Shalabi: Clopidogrel, Aspirin, and the Role of PPIs in Coronary Artery Disease
-
Mar 6, 2026, 16:17Paul McKenzie: The Value of Gene Therapy in Bleeding Disorders
-
Mar 6, 2026, 16:15Basma El Homasany: The ‘Little Brain’ of the Heart and Its Role in Health
-
Mar 6, 2026, 16:14Jamal Rana: Family History and Polygenic Risk for Coronary Heart Disease
-
Mar 6, 2026, 15:43Kristy Ainslie: Breaking Down the Discovery and FDA Approval of Drug Carriers
-
Mar 6, 2026, 15:18Claudio Laudani: Efficacy and Safety of Colchicine for Secondary Prevention in Coronary Artery Disease
-
Mar 6, 2026, 15:09Chris Simon: Persona PLUS Receives FDA Clearance for Patent‑Protected Plasma Apheresis